{"nctId":"NCT00955513","briefTitle":"Evaluate the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel Applied Twice or Three Times Daily in Patients With Acute Ankle Sprain","startDateStruct":{"date":"2009-07"},"conditions":["Grade I/II Ankle Sprain"],"count":242,"armGroups":[{"label":"diclofenac diethylamine gel 2.32% gel twice a day","type":"EXPERIMENTAL","interventionNames":["Drug: diclofenac diethylamine gel 2.32%"]},{"label":"diclofenac diethylamine gel 2.32% gel three times a day","type":"EXPERIMENTAL","interventionNames":["Drug: diclofenac diethylamine gel 2.32%"]},{"label":"placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"diclofenac diethylamine gel 2.32%","otherNames":[]},{"name":"diclofenac diethylamine gel 2.32%","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1\\. Acute sprain of the lateral ankle, Grade I-II .\n\nExclusion Criteria:\n\n1. Any concurrent injury affecting the lower extremities that is painful at rest or on movement, or could affect the mobilization of the patient.\n2. Topical analgesic or anti-inflammatory treatment over the previous month in the area to be treated.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Measure: Pain on Movement on Day 5 (Change From Baseline).","description":"Visual analog scale (0 to 100 mm) A greater change from baseline equates to a better outcome.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"49.1","spread":"19.3"},{"groupId":"OG001","value":"49.7","spread":"21.5"},{"groupId":"OG002","value":"25.4","spread":"14.8"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":80},"commonTop":["Headache"]}}}